Zobrazeno 1 - 10
of 1 063
pro vyhledávání: '"Translational Therapeutics"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Osteosarcoma is a malignant primary tumor of bone, arising from transformed progenitor cells with osteoblastic differentiation and osteoid production. While categorized as a rare tumor, most patients diagnosed with osteosarcoma are adolescents in the
Externí odkaz:
https://doaj.org/article/b6f1a0df81d247859fdae0aceac0e9a5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xin Wang, Hong Zhao, Bin S. Teh, Monika Vishnoi, Stephen T. C. Wong, Jenny C. Chang, Robert C. Rostomily, Ding Ren, Hao Cheng
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Systemic therapies for primary breast cancer have made great progress over the past two decades. However, oncologists confront an insidious and particularly difficult problem: in those patients with metastatic breast cancer, up to 50% of human epider
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e822d73dd3466edc32542f6788f424d2
https://pubmed.ncbi.nlm.nih.gov/32655700
https://pubmed.ncbi.nlm.nih.gov/32655700
Autor:
Yao Lin, A. Robertson, Duncan I. Jodrell, Jo L. Bramhall, Jennifer Harrington, Daniella Zheleva, Tashinga E. Bapiro, Frances M. Richards, B-F Krippendorff
Publikováno v:
British Journal of Cancer
BACKGROUND: Amplification of aurora kinase A (AK-A) overrides the mitotic spindle assembly checkpoint, inducing resistance to taxanes. RNA interference targeting AK-A in human pancreatic cancer cell lines enhanced taxane chemosensitivity. In this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac2a40840c1c7c497781bc2aeb45ad98
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Osteosarcoma is a malignant primary tumor of bone, arising from transformed progenitor cells with osteoblastic differentiation and osteoid production. While categorized as a rare tumor, most patients diagnosed with osteosarcoma are adolescents in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c432ad60b5a0c8d577eba82c40495265
https://www.frontiersin.org/article/10.3389/fonc.2020.00013/full
https://www.frontiersin.org/article/10.3389/fonc.2020.00013/full
Publikováno v:
British Journal of Cancer
Background: Adoptive transfer of genetically engineered T-cells to express antigen-specific T-cell receptor (TCR) is a feasible and effective therapeutic approach for numerous types of cancers, including Epstein–Barr virus (EBV)-associated malignan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad57e1474d14f9ebab668806188ba33
https://doi.org/10.1038/bjc.2017.475
https://doi.org/10.1038/bjc.2017.475
Autor:
Mei Zhao, Hailong Ma, Shufang Jin, Wen-Yi Yang, Ge Zhou, Jingzhou Hu, Sijie Fang, Zhiyuan Zhang
Publikováno v:
British Journal of Cancer
Background: The epidermal growth factor receptor (EGFR)-targeted therapies have been tested in the clinic as treatments for head and neck squamous cell carcinoma (HNSCC). Owing to intrinsic or acquired resistance, EGFR-targeted therapies often lead t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb5c8c77b5d3f1a2c17547958131e29d
https://doi.org/10.1038/bjc.2017.442
https://doi.org/10.1038/bjc.2017.442
Autor:
Junnian Zheng, Hong Yao, Zan Shen, Peng-Jin Mei, Gang Wang, Qing Zhang, Hsiangfu Kung, Jian Zhang, Qian Zhang, Wenyan Zhang, Raymond Zhang, Longzhen Zhang, Xiaoge Gao, Marie C. Lin, Mengxue Wei, William K C Cheung, Hong-Lin Chen, Rui Duan
Publikováno v:
British Journal of Cancer
Background: The therapeutic resistance to ionising radiation (IR) and anti-angiogenesis mainly impair the prognosis of patients with glioblastoma. The primary and secondary MET aberrant activation is one crucial factor for these resistances. The krin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::636b6dc1f7ac96287e33597da089ba98
https://doi.org/10.1038/bjc.2017.461
https://doi.org/10.1038/bjc.2017.461